Safety and Efficacy of Ofatumumab, a Fully Human Monoclonal Anti-Cd20 Antibody, in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: A Phase 1-2 Study
Blood - United States
doi 10.1182/blood-2007-09-111781
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2008
Authors
Publisher
American Society of Hematology